1. Home
  2. INFQ vs SUPN Comparison

INFQ vs SUPN Comparison

Compare INFQ & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INFQ

Infleqtion Inc. Common Stock

N/A

Current Price

$10.35

Market Cap

2.9B

Sector

Technology

ML Signal

N/A

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.22

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INFQ
SUPN
Founded
2007
2005
Country
United States
United States
Employees
205
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2026
2010

Fundamental Metrics

Financial Performance
Metric
INFQ
SUPN
Price
$10.35
$47.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$20.00
$61.60
AVG Volume (30 Days)
15.0M
950.3K
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$25.46
$22.70
Revenue Next Year
$25.00
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.52
$32.21
52 Week High
$21.28
$59.68

Technical Indicators

Market Signals
Indicator
INFQ
SUPN
Relative Strength Index (RSI) 36.01 51.25
Support Level $8.54 $43.43
Resistance Level $12.22 $52.36
Average True Range (ATR) 1.16 1.60
MACD -0.30 0.34
Stochastic Oscillator 0.48 42.55

Price Performance

Historical Comparison
INFQ
SUPN

About INFQ Infleqtion Inc. Common Stock

Infleqtion Inc developing and commercializing quantum technology products as part of a full-stack platform, which currently includes offerings such as quantum sensing, quantum computing, and software. Its quantum-enabled solutions are focused on addressing the world's pressing challenges, with technologies actively deployed across some sectors today, including defense and security, artificial intelligence (AI), energy optimization, space and frontier, materials discovery, and cybersecurity.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: